- Home
- DBVT vs ASM Comparison
DBVT vs ASM Comparison
Compare DBVT & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DBVT | ASM |
|---|---|---|
| Founded | 2002 | 1968 |
| Country | France | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 769.4M | 920.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DBVT | ASM |
|---|---|---|
| Price | $17.61 | $6.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $31.75 | $5.27 |
| AVG Volume (30 Days) | 611.1K | ★ 5.3M |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 476.57 |
| EPS | N/A | ★ 0.14 |
| Revenue | $5,502,000.00 | ★ $86,065,000.00 |
| Revenue This Year | $1,768.71 | $38.58 |
| Revenue Next Year | $1,028.88 | $39.81 |
| P/E Ratio | ★ N/A | $47.58 |
| Revenue Growth | N/A | ★ 58.42 |
| 52 Week Low | $3.30 | $0.88 |
| 52 Week High | $26.19 | $6.98 |
Technical Indicators
Market Signals| Indicator | DBVT | ASM |
|---|---|---|
| Relative Strength Index (RSI) | 49.42 | 49.34 |
| Support Level | $16.49 | $5.73 |
| Resistance Level | $19.62 | $6.48 |
| Average True Range (ATR) | 1.49 | 0.38 |
| MACD | -0.50 | -0.10 |
| Stochastic Oscillator | 11.76 | 20.72 |
Price Performance
Historical ComparisonAbout DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.